Umuthi wokugomela i-COVID-19 othuthukiswe yiSinopharm yaseChina ukuze usetshenziswe ezimweni eziphuthumayo, ugunyazwe yi-WHO.

Umuthi wokugomela i-COVID-19 owenziwe yi-Sinopharm yaseChina

ukusetshenziswa okuphuthumayo, kugunyazwe yi-WHO.

IInhlangano Yezempilo Yomhlaba (WHO)waqinisekiswa ngoMeyi wesikhombisa umuthi wokugomela i-BBIBP-CorV COVID-19 othuthukiswe yi-Sinopharm yaseChina ukuze usetshenziswe izimo eziphuthumayo.

Namuhla ntambama, i-WHO inikeze uhlu olusetshenziswa ezimeni eziphuthumayo emuthini wokugomela i-Sinopharm Beijing we-COVID-19, okwenza kwaba umgomo wesithupha ukuthola ukuqinisekiswa kwe-WHO ngokuphepha, ukusebenza kahle kanye nekhwalithi, "kusho uMqondisi-Jikelele we-WHO uDkt. Tedros Adhanom Ghebreyesus esithangamini nabezindaba.

Lokhu kwandisa uhlu lwemithi yokugoma engathengwa yi-COVAX, futhi kunikeza amazwe ukuzethemba kokusheshisa ukugunyazwa kwawo okulawulwayo, kanye nokungenisa nokuphatha umgomo.

 

Kuwudumo olukhulu lokhoIsixazululo sokuhlola i-endotoxin ye-Bioendoukunikela ngomzamo othile ekulawuleni ikhwalithi yokutholwa kwe-endotoxin ekuthuthukisweni nasekukhiqizweni komgomo we-COVID-19 e-China.

Sithemba ukuthi abantu emhlabeni wonke bazojabulela isikhathi esinokuthula nempilo enhle.

 

·Le ndatshana icaphuna e-China Daily Bilingual News.